| 1 |
001-01 |
CRS Acticomp Umifenovir hydrochloride monohydrate 100 mg |
7000 ₽ |
| 2 |
001-02 |
CRS Acticomp Umifenovir for system suitability (mixture of Umifenovir hydrochloride monohydrate and impurities A, B, C, D, E) 20 mg |
8500 ₽ |
| 3 |
014-01 |
CRS Acticomp Fluconazole 200 mg |
9500 ₽ |
| 4 |
030-01 |
CRS Acticomp Meloxicam 400 mg |
7000 ₽ |
| 5 |
030-02 |
CRS Acticomp Meloxicam Impurity B 50 mg |
8500 ₽ |
| 6 |
034-03 |
CRS Acticomp N-nitroso-N-(methyl-d₃)-4-aminobutyric acid 10 mg |
69000 ₽ |
| 7 |
034-02 |
CRS Acticomp N-nitrosodimethylamine-d₆ 10 mg |
23000 ₽ |
| 8 |
039-01 |
CRS Acticomp Tilorone dihydrochloride 100 mg |
7000 ₽ |
| 9 |
039-02 |
CRS Acticomp 2-(Diethylamino)ethyl chloride hydrochloride 150 mg |
8500 ₽ |
| 10 |
044-01 |
CRS Acticomp Sildenafil citrate 200 mg |
7000 ₽ |
| 11 |
044-02 |
CRS Acticomp Sildenafil for system suitability (mixture of Sildenafil citrate and impurities A, D) 15 mg |
8500 ₽ |
| 12 |
050-01 |
CRS Acticomp Piribedil 100 mg |
7000 ₽ |
| 13 |
051-01 |
CRS Acticomp Febuxostat 100 mg |
7000 ₽ |
| 14 |
051-02 |
CRS Acticomp Febuxostat impurity B 50 mg |
6000 ₽ |
| 15 |
051-03 |
CRS Acticomp Febuxostat impurity C 25 mg |
6000 ₽ |
| 16 |
051-04 |
CRS Acticomp Febuxostat impurity D 25 mg |
6000 ₽ |
| 17 |
055-01 |
CRS Acticomp Ketoprofen 200 mg |
7000 ₽ |
| 18 |
055-02 |
CRS Acticomp Dexketoprofen trometamol 50 mg |
7000 ₽ |
| 19 |
055-03 |
CRS Acticomp Ketoprofen for system suitability (mixture of Ketoprofen trometamol and impurities A, B, D, H, I, J, K) 50 mg |
8500 ₽ |
| 20 |
055-04 |
CRS Acticomp R-Ketoprofen trometamol 50 mg |
11500 ₽ |
| 21 |
056-01 |
CRS Acticomp Ebastine impurity C 10 mg |
6000 ₽ |
| 22 |
056-02 |
CRS Acticomp Ebastine impurity D 10 mg |
6000 ₽ |
| 23 |
056-03 |
CRS Acticomp Ebastine impurity H 110 mg |
6000 ₽ |
| 24 |
056-05 |
CRS Acticomp Ebastine 300 mg |
6000 ₽ |
| 25 |
056-07 |
CRS Acticomp Ebastine impurity A 100 mg |
6000 ₽ |
| 26 |
057-01 |
CRS Acticomp Oxyethylammonium methylphenoxyacetate 100 mg |
7000 ₽ |
| 27 |
057-02 |
CRS Acticomp 2-Phenoxyacetic acid 100 mg |
7000 ₽ |
| 28 |
057-03 |
CRS Acticomp o-Cresol 500 mg |
7000 ₽ |
| 29 |
057-04 |
CRS Acticomp 2-(3-Methylphenoxy) acetic acid 100 mg |
7000 ₽ |
| 30 |
057-05 |
CRS Acticomp 2-(4-Methylphenoxy) acetic acid 100 mg |
7000 ₽ |
| 31 |
057-06 |
CRS Acticomp o-Cresoxy acetic acid 100 mg |
7000 ₽ |
| 32 |
058-01 |
CRS Acticomp Pazopanib hydrochloride 200 mg |
7000 ₽ |
| 33 |
058-02 |
CRS Acticomp Pazopanib for system suitability (mixture of Pazopanib hydrochloride and impurities C, D, E) 50 mg |
8500 ₽ |
| 34 |
061-01 |
CRS Acticomp Etoricoxib 200 mg |
7000 ₽ |
| 35 |
061-02 |
CRS Acticomp Etoricoxib for peak identification (mixture of Etoricoxib and impurities B, C, D, E) 10 mg |
8500 ₽ |
| 36 |
063-01 |
CRS Acticomp Nilotinib hydrochloride monohydrate 200 mg |
7000 ₽ |
| 37 |
063-02 |
CRS Acticomp Nilotinib for system suitability (mixture of Nilotinib hydrochloride monohydrate and impurities D, E, F, G, H) 20 mg |
8500 ₽ |
| 38 |
063-03 |
CRS Acticomp Nilotinib impurity A 100 mg |
11500 ₽ |
| 39 |
063-04 |
CRS Acticomp Nilotinib impurity B 50 mg |
17500 ₽ |
| 40 |
063-05 |
CRS Acticomp Nilotinib impurity C 50 mg |
17500 ₽ |
| 41 |
063-06 |
CRS Acticomp Nilotinib impurity DMAP 50 mg |
11500 ₽ |
| 42 |
064-01 |
CRS Acticomp Sorafenib tosylate 200 mg |
7000 ₽ |
| 43 |
064-02 |
CRS Acticomp Sorafenib for system suitability (mixture of Sorafenib tosylate and impurities A, D, H, I, L, M)30 mg |
8500 ₽ |
| 44 |
065-01 |
CRS Acticomp Ipidacrine 100 mg |
8500 ₽ |
| 45 |
065-02 |
CRS Acticomp Ipidacrine Impurity D 50 mg |
11500 ₽ |
| 46 |
065-03 |
CRS Acticomp Ipidacrine impurity A 100 mg |
35000 ₽ |
| 47 |
065-04 |
CRS Acticomp Ipidacrine impurity B 100 mg |
35000 ₽ |
| 48 |
067-01 |
CRS Acticomp Inosine pranobex 200 mg |
11500 ₽ |
| 49 |
067-02 |
CRS Acticomp Inosine 200 mg |
6000 ₽ |
| 50 |
067-03 |
CRS Acticomp 4-acetamidobenzoic acid 250 mg |
6000 ₽ |
| 51 |
067-04 |
CRS Acticomp Hypoxanthine 100 mg |
7000 ₽ |
| 52 |
067-05 |
CRS Acticomp 4-Aminobenzoic acid 100 mg |
7000 ₽ |
| 53 |
067-06 |
CRS Acticomp Guanosine 150 mg |
7000 ₽ |
| 54 |
068-01 |
CRS Acticomp Vildagliptin 50 mg |
7000 ₽ |
| 55 |
068-02 |
CRS Acticomp Vildagliptin for peak identification (mixture of Vildagliptin and impurities A, B, C, F) 50 mg |
8500 ₽ |
| 56 |
068-03 |
CRS Acticomp Vildagliptin for system suitability (mixture of Vildagliptin and impurity E) 50 mg |
8500 ₽ |
| 57 |
070-01 |
CRS Acticomp Silodosin 100 mg |
7000 ₽ |
| 58 |
070-02 |
CRS Acticomp Silodosin for system suitability (mixture of Silodosin and impurity E) 20 mg |
9500 ₽ |
| 59 |
071-01 |
CRS Acticomp Sodium lauryl sulfoacetate 100 mg |
7000 ₽ |
| 60 |
071-02 |
CRS Acticomp Dodecyl-2-chloroacetate 200 mg |
8500 ₽ |
| 61 |
074-01 |
CRS Acticomp Favipiravir 200 mg |
7000 ₽ |
| 62 |
074-03 |
CRS Acticomp Favipiravir for peak identification (mixture of Favipiravir and impurities FVP-Cl, SP2) 10 mg |
8500 ₽ |
| 63 |
076-01 |
CRS Acticomp Clopidogrel hydrogen sulfate (form II) 100 mg |
7000 ₽ |
| 64 |
078-01 |
CRS Acticomp Rivaroxaban 150 mg |
7000 ₽ |
| 65 |
078-02 |
CRS Acticomp Rivaroxaban impurity A 25 mg |
8500 ₽ |
| 66 |
078-03 |
CRS Acticomp Rivaroxaban for system suitability (mixture of Rivaroxaban and impurity F) 25 mg |
8500 ₽ |
| 67 |
078-04 |
CRS Acticomp Rivaroxaban for peak identification (mixture of Rivaroxaban and impurities R, O, D, P, E, C, G, H, I) 25 mg |
8500 ₽ |
| 68 |
079-01 |
CRS Acticomp Gliclazide 200 mg |
7000 ₽ |
| 69 |
079-02 |
CRS Acticomp Gliclazide for system suitability (mixture of Gliclazide and impurities A, F, K) 30 mg |
8500 ₽ |
| 70 |
079-03 |
CRS Acticomp Gliclazide Impurity F 50 mg |
8500 ₽ |
| 71 |
079-04 |
CRS Acticomp Gliclazide Impurity B 50 mg |
11500 ₽ |
| 72 |
080-01 |
CRS Acticomp Darunavir ethanolate 50 mg |
7000 ₽ |
| 73 |
080-02 |
CRS Acticomp Darunavir for system suitability (mixture of Darunavir ethanolate and impurities A, B, C, F, G) 30 mg |
8500 ₽ |
| 74 |
083-01 |
CRS Acticomp Dapagliflozin 200 mg |
7000 ₽ |
| 75 |
083-02 |
CRS Acticomp Dapagliflozin for system suitability (mixture of Dapagliflozin and impurities A, B) 40 mg |
8500 ₽ |
| 76 |
084-01 |
CRS Acticomp Molnupiravir 200 mg |
7000 ₽ |
| 77 |
084-02 |
CRS Acticomp Molnupiravir for peak identification (mixture of Molnupiravir and impurities A, B) 50 mg |
8500 ₽ |
| 78 |
087-01 |
CRS Acticomp Deferasirox 100 mg |
7000 ₽ |
| 79 |
087-03 |
CRS Acticomp Deferasirox for system suitability (mixture of Deferasirox and impurities A, C, D, E) 30 mg |
8500 ₽ |
| 80 |
087-02 |
CRS Acticomp Deferasirox Impurity B 30 mg |
8500 ₽ |
| 81 |
087-04 |
CRS Acticomp Deferasirox Impurity F 25 mg |
8500 ₽ |
| 82 |
088-01 |
CRS Acticomp Sitagliptin phosphate monohydrate 200 mg |
7000 ₽ |
| 83 |
088-02 |
CRS Acticomp Sitagliptin for system suitability (mixture of Sitagliptin phosphate monohydrate and impurities B, C, D, E, F, G) 25 mg |
8500 ₽ |
| 84 |
088-03 |
CRS Acticomp Sitagliptin containing impurity A 40 mg |
8500 ₽ |
| 85 |
088-04 |
CRS Acticomp Sitagliptin impurity NTTP 40 mg |
86000 ₽ |
| 86 |
089-01 |
CRS Acticomp Eltrombopag olamine 200 mg |
7000 ₽ |
| 87 |
089-02 |
CRS Acticomp Eltrombopag for system suitability (mixture of Eltrombopag olamine and impurities D, N, M) 20 mg |
8500 ₽ |
| 88 |
090-01 |
CRS Acticomp Axitinib 200 mg |
7000 ₽ |
| 89 |
090-02 |
CRS Acticomp Axitinib for system suitability (mixture of Axitinib and impurities A, B, C, D, G, H, I, J) 30 mg |
8500 ₽ |
| 90 |
091-01 |
CRS Acticomp Tranexamic acid 250 mg |
7000 ₽ |
| 91 |
091-02 |
CRS Acticomp Tranexamic acid impurity D 30 mg |
8500 ₽ |
| 92 |
091-03 |
CRS Acticomp Tranexamic acid impurity E 30 mg |
8500 ₽ |
| 93 |
091-04 |
CRS Acticomp Tranexamic acid for system suitability (mixture of Tranexamic acid and impurities B, C, D, E, F) 20 mg |
8500 ₽ |
| 94 |
092-01 |
CRS Acticomp Ethylmethylhydroxypyridine succinate 200 mg |
7000 ₽ |
| 95 |
092-02 |
CRS Acticomp Ethylmethylhydroxypyridine for peak identification (mixture of Ethylmethylhydroxypyridine succinate and impurities A, D) 10 mg |
8500 ₽ |
| 96 |
093-01 |
CRS Acticomp Ticagrelor 200 mg |
7000 ₽ |
| 97 |
093-02 |
CRS Acticomp Ticagrelor for system suitability (mixture of Ticagrelor and impurities A, B, C, D, F, G, H) 30 mg |
8500 ₽ |
| 98 |
093-03 |
CRS Acticomp Ticagrelor impurity E 50 mg |
11500 ₽ |
| 99 |
094-01 |
CRS Acticomp Apixaban 200 mg |
7000 ₽ |
| 100 |
094-02 |
CRS Acticomp Apixaban for system suitability (mixture of Apixaban and impurities A, C, D, E, G, I, M) 25 mg |
8500 ₽ |
| 101 |
096-01 |
CRS Acticomp Sunitinib malate 200 mg |
7000 ₽ |
| 102 |
096-02 |
CRS Acticomp Sunitinib for system suitability (mixture of Sunitinib malate and impurities B, C, D, F, G, H) 20 mg |
8500 ₽ |
| 103 |
097-01 |
CRS Acticomp Temgicoluril 200 mg |
7000 ₽ |
| 104 |
097-02 |
CRS Acticomp Temgicoluril for system suitability (mixture of Temgicoluril and impurities A, E, F) 25 mg |
10500 ₽ |
| 105 |
098-01 |
CRS Acticomp Alogliptin benzoate 150 mg |
7000 ₽ |
| 106 |
098-02 |
CRS Acticomp Alogliptin for system suitability (mixture of Alogliptin benzoate and impurities C, D, E, G) 25 mg |
14000 ₽ |
| 107 |
100-01 |
CRS Acticomp Tadalafil 200 mg |
7000 ₽ |
| 108 |
102-01 |
CRS Acticomp Roxadustat 200 mg |
7000 ₽ |
| 109 |
102-02 |
CRS Acticomp Roxadustat for system suitability (mixture of Roxadustat and impurities A, B, C, D, E, F) 30 mg |
8500 ₽ |